An Outline of Haematopoietic Stem Cell Transplantation
Major strides have occurred in the field of haematopoietic stem cell transplantation over the past few decades. Patients with life threatening blood disorders like advanced leukaemia, genetic immunedeficiency and haemoglobinopathies can now be offered a curative option. Advances in graft manipulation, immune modulation and alternative donor sources such as large volunteer donor registries and umbilical cord blood stem cell banks have ensured that every patient has a donor to offer the chance of cure.
KeywordsGraft Versus Host Disease Haematopoietic Stem Cell Transplantation Haematopoietic Stem Cell Cord Blood Transplant Sinusoidal Obstruction Syndrome
- 1.Meisel R, Enczmann J, Balzer S et al (2005) Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single centre comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Klin Padiatr 217(3):135–141PubMedCrossRefGoogle Scholar
- 4.Bearnian SI, Lee JL, Baron AB (1997) Treatment of hepatic verioocclusive disease with recombinant human tissue plasminogen activator, and heparin in 42 marrow transplant patients. Blood 89:1501–1506Google Scholar
- 6.Ravindranath Y, Chang M, Steuber CP et al, Pediatric Oncology Group (2005) Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 19(12):2101–2116Google Scholar
- 9.Badell I, Munoz A, Ortega JJ et al, Spanish Working Party for BMT in Children (GETMON) (2005) Long-terrn outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983–1998. Bone Marrow Transplant 35(9):895–901Google Scholar
- 16.Wall DA, Carter SL, Kernan NA et al, COBLT Steering Committee (2005) Busulfan! melphalan! antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. BioI Blood Marrow Transplant 11(8): 637–646Google Scholar